Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure.


Journal

The pharmacogenomics journal
ISSN: 1473-1150
Titre abrégé: Pharmacogenomics J
Pays: United States
ID NLM: 101083949

Informations de publication

Date de publication:
10 2019
Historique:
received: 03 08 2017
accepted: 21 12 2018
revised: 04 11 2018
pubmed: 18 1 2019
medline: 9 7 2020
entrez: 18 1 2019
Statut: ppublish

Résumé

Heart failure (HF) is associated with perturbations of the interleukin-6 (IL-6) signaling pathway. A total of 559 Danish subjects with severe chronic HF enrolled in the previously reported Echocardiography and Heart Outcome Study were genotyped for three SNPs in IL6, nine in the IL-6 receptor gene (IL6R), and two in the IL-6 signal transducer gene (IL6ST). After a mean follow-up of 5.0 years, 5 SNPs in IL6R introns (rs12083537, rs6684439, rs4845622, rs4537545, and rs7529229) and a SNP in the IL6R coding region (rs2228145, also known as Asp358Ala) were associated with adverse outcomes, e.g., hazard ratios (HRs) for cardiovascular death and all-cause death 1.38 (CI: 1.09-1.76; P = 0.008) and 1.37 (CI: 1.10-1.70; P = 0.004) for rs6684439 heterozygotes, and 1.39 (CI: 1.09-1.77; P = 0.007) and 1.37 (CI: 1.10-1.70; P = 0.005) for rs4845622 heterozygotes, respectively. We conclude that SNPs in the IL-6 signaling pathway may be independent predictors of fatal outcomes in patients with severe HF.

Identifiants

pubmed: 30651573
doi: 10.1038/s41397-019-0068-2
pii: 10.1038/s41397-019-0068-2
doi:

Substances chimiques

IL6ST protein, human 0
Receptors, Interleukin-6 0
Cytokine Receptor gp130 133483-10-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

428-437

Auteurs

Peter R Hansen (PR)

Department of Cardiology, Herlev-Gentofte Hospital, DK-2900, Hellerup, Denmark. prh@dadlnet.dk.
Section for Periodontology, Department of Odontology, Faculty of Health and Medical Sciences, Copenhagen University, DK-2100, Copenhagen, Denmark. prh@dadlnet.dk.

Karl Emil Nelveg-Kristensen (KE)

Department of Nephrology, Rigshospitalet, DK-2100, Copenhagen, Denmark.

Henrik B Rasmussen (HB)

Institute of Biological Psychiatry, Mental Health Centre Sct. Hans, Copenhagen University Hospital, DK-4000, Roskilde, Denmark.
Department of Science and Environment, Roskilde University, Universitetsvej 1, DK-4000, Roskilde, Denmark.

Christian Torp-Pedersen (C)

Department of Health and Science Technology, Aalborg University, DK-9100, Aalborg, Denmark.

Lars Køber (L)

Department of Cardiology, Rigshospitalet, DK-2100, Copenhagen, Denmark.

Claus Henrik Nielsen (CH)

Section for Periodontology, Department of Odontology, Faculty of Health and Medical Sciences, Copenhagen University, DK-2100, Copenhagen, Denmark.
Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, DK-2100, Copenhagen, Denmark.

Christian Enevold (C)

Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, DK-2100, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH